Literature DB >> 10612716

Fast determination of haptoglobin phenotype and calculation of hemoglobin binding capacity using high pressure gel permeation chromatography.

J Delanghe1, K Allcock, M Langlois, L Claeys, M De Buyzere.   

Abstract

A new and fast method for haptoglobin (Hp) phenotyping was developed based on high pressure gel permeation chromatography of hemoglobin-supplemented serum. Haptoglobin phenotypes 1-1, 2-1, and 2-2 are resolved on the difference in size of their hemoglobin-haptoglobin complexes. Results are available in less than 15 min. Results of the chromatographic typing correspond to those obtained by conventional starch gel electrophoresis. Next to the phenotyping of haptoglobin, the method allows reproducible calculation of the hemoglobin binding capacity (HBC) of human serum. Using this methodology, reference values for HBC were found to be 0. 75+/-0.25 g/l, with the lowest HBC in Hp 2-2 subjects and the highest in Hp 1-1 subjects (P<0.05). In contrast to earlier findings, the ratio HBC:Hp concentration was found to be comparable for the three Hp types. In conclusion, this method allows a rapid phenotyping in critical clinical conditions where Hp phenotyping can be useful, e.g. determining the donor's phenotype in liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10612716     DOI: 10.1016/s0009-8981(99)00194-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

1.  Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in guinea pigs to attenuate hemoglobin toxicity.

Authors:  Miriam Lipiski; Jeremy W Deuel; Jin Hyen Baek; Wolfgang R Engelsberger; Paul W Buehler; Dominik J Schaer
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

2.  The absence of the CD163 receptor has distinct temporal influences on intracerebral hemorrhage outcomes.

Authors:  Jenna L Leclerc; Andrew S Lampert; Claudia Loyola Amador; Brandon Schlakman; Terrie Vasilopoulos; Pia Svendsen; Søren K Moestrup; Sylvain Doré
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-30       Impact factor: 6.200

3.  Haptoglobin genotype and functional outcome after aneurysmal subarachnoid hemorrhage.

Authors:  Ellen Kantor; Hülya Bayır; Dianxu Ren; J Javier Provencio; Laura Watkins; Elizabeth Crago; Michael B Horowitz; Robert E Ferrell; Yvette P Conley; Sheila A Alexander
Journal:  J Neurosurg       Date:  2013-11-29       Impact factor: 5.115

4.  Haptoglobin genotype and outcome after aneurysmal subarachnoid haemorrhage.

Authors:  Matthew J Morton; Isabel C Hostettler; Nabila Kazmi; Varinder S Alg; Stephen Bonner; Martin M Brown; Andrew Durnford; Benjamin Gaastra; Patrick Garland; Joan Grieve; Neil Kitchen; Daniel Walsh; Ardalan Zolnourian; Henry Houlden; Tom R Gaunt; Diederik O Bulters; David J Werring; Ian Galea
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-01-14       Impact factor: 10.154

Review 5.  Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development.

Authors:  Dominik J Schaer; Francesca Vinchi; Giada Ingoglia; Emanuela Tolosano; Paul W Buehler
Journal:  Front Physiol       Date:  2014-10-28       Impact factor: 4.566

6.  Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-α in macrophages.

Authors:  Anders Etzerodt; Mie Rostved Rasmussen; Pia Svendsen; Athena Chalaris; Jeanette Schwarz; Ian Galea; Holger Jon Møller; Søren Kragh Moestrup
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

7.  Haptoglobin genotype and risk markers of cardiovascular disease in patients with chronic kidney disease.

Authors:  Charlotte Strandhave; My Svensson; Henrik Krarup; Jeppe Hagstrup Christensen
Journal:  Int J Nephrol       Date:  2013-03-16

Review 8.  A review of haptoglobin typing methods for disease association study and preventing anaphylactic transfusion reaction.

Authors:  Dae-Hyun Ko; Ho Eun Chang; Taek Soo Kim; Eun Young Song; Kyoung Un Park; Junghan Song; Kyou Sup Han
Journal:  Biomed Res Int       Date:  2013-02-28       Impact factor: 3.411

9.  The critical care management of poor-grade subarachnoid haemorrhage.

Authors:  Airton Leonardo de Oliveira Manoel; Alberto Goffi; Tom R Marotta; Tom A Schweizer; Simon Abrahamson; R Loch Macdonald
Journal:  Crit Care       Date:  2016-01-23       Impact factor: 9.097

Review 10.  Iron Metabolism at the Interface between Host and Pathogen: From Nutritional Immunity to Antibacterial Development.

Authors:  Marialaura Marchetti; Omar De Bei; Stefano Bettati; Barbara Campanini; Sandra Kovachka; Eleonora Gianquinto; Francesca Spyrakis; Luca Ronda
Journal:  Int J Mol Sci       Date:  2020-03-20       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.